Effect of genetic background on onset and disease progression in the SOD1-G93A model of amyotrophic lateral sclerosis

被引:46
|
作者
Mancuso, Renzo [2 ,3 ]
Olivan, Sara [4 ]
Mancera, Pilar [5 ]
Pasten-Zamorano, Andrea [5 ]
Manzano, Raquel [4 ]
Casas, Caty [2 ,3 ]
Osta, Rosario [4 ]
Navarro, Xavier [1 ,2 ,3 ]
机构
[1] Univ Autonoma Barcelona, Fac Med, Unitat Fisiol Med, Grp Neuroplast & Regenerat,Inst Neurosci, E-08193 Bellaterra, Spain
[2] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, E-08193 Bellaterra, Spain
[3] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra, Spain
[4] Univ Zaragoza, Aragon Inst Hlth Sci, Lab Genet Biochem LAGENBIO I3A, Zaragoza, Spain
[5] Bioincubadora PCB Santander, Neurotec Pharma SL, Barcelona, Spain
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2012年 / 13卷 / 03期
关键词
Motor neuron disease; neurodegeneration; SOD1-G93A mouse; background; animal model; TRANSGENIC MOUSE MODEL; SUPEROXIDE-DISMUTASE; HEXANUCLEOTIDE REPEAT; ALS; SURVIVAL; MICE; MUTATIONS; NEUROINFLAMMATION; EPIDEMIOLOGY; DEGENERATION;
D O I
10.3109/17482968.2012.662688
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Knowledge of the potential effect of genetic background in disease models is important. The SOD1-G93A transgenic mouse is the most widely used model in amyotrophic lateral sclerosis (ALS). Since these animals show considerable variability both in the onset and the progression of the disease, this study aimed to characterize the potential differences between the two most widely used strains, C56BL/6 (B6) and B6SJL. A rotarod test was carried out to assess strength and motor coordination, while electrophysiology tests were performed to evaluate the function of upper and lower motor neurons. Survival of the animals and motor neuron loss were also studied. The results did not show any background effect regarding the rotarod test, despite the differences in the pattern of decline in central and peripheral motor conduction. The onset of motor neuron abnormalities was later in B6SJL mice, but progressed more rapidly. Lifespan was longer for B6 than for B6SJL animals. In conclusion, background differences in disease onset and progression are important. The characteristics of the strain should be taken into account in experimental design of therapeutic studies.
引用
收藏
页码:302 / 310
页数:9
相关论文
共 50 条
  • [21] Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis
    Eric J. Granucci
    Ana Griciuc
    Kaly A. Mueller
    Alexandra N. Mills
    Hoang Le
    Amanda M. Dios
    Danielle McGinty
    Joao Pereira
    David Elmaleh
    James D. Berry
    Sabrina Paganoni
    Merit E. Cudkowicz
    Rudolph E. Tanzi
    Ghazaleh Sadri-Vakili
    Scientific Reports, 9
  • [22] Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis
    Granucci, Eric J.
    Griciuc, Ana
    Mueller, Kaly A.
    Mills, Alexandra N.
    Le, Hoang
    Dios, Amanda M.
    McGinty, Danielle
    Pereira, Joao
    Elmaleh, David
    Berry, James D.
    Paganoni, Sabrina
    Cudkowicz, Merit E.
    Tanzi, Rudolph E.
    Sadri-Vakili, Ghazaleh
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [23] Transcranial Focused Ultrasound Modifies Disease Progression in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
    Hong, Zhongqiu
    Yi, Shasha
    Deng, Miaoqin
    Zhong, Yongsheng
    Zhao, Yun
    Li, Lili
    Zhou, Hui
    Xiao, Yang
    Hu, Xiquan
    Niu, Lili
    IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL, 2025, 72 (02) : 191 - 201
  • [24] Evaluation of Neuropathological Features in the SOD1-G93A Low Copy Number Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
    Molnar-Kasza, Agnes
    Hinteregger, Barbara
    Neddens, Joerg
    Rabl, Roland
    Flunkert, Stefanie
    Hutter-Paier, Birgit
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 14
  • [25] Plasma neurofilament levels as a biomarker of disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
    Gnanapavan, S.
    Kalmar, B.
    Keir, G.
    Petzold, A.
    Giovanonni, G.
    Greensmith, L.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (03): : 358 - 358
  • [26] Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis
    Ahn, Suk-Won
    Jeon, Gye Sun
    Kim, Myung-Jin
    Shon, Jee-Heun
    Kim, Jee-Eun
    Shin, Je-Young
    Kim, Sung-Min
    Kim, Seung Hyun
    Ye, In-Hae
    Lee, Kwang-Woo
    Hong, Yoon-Ho
    Sung, Jung-Joon
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) : 112 - 116
  • [27] Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models
    Milani, Martina
    Della Valle, Ilaria
    Rossi, Simona
    Fabbrizio, Paola
    Margotta, Cassandra
    Nardo, Giovanni
    Cozzolino, Mauro
    D'Ambrosi, Nadia
    Apolloni, Savina
    NEUROTHERAPEUTICS, 2024, 21 (03)
  • [28] Neuroprotective effect of bexarotene in the SOD1G93A mouse model of amyotrophic lateral sclerosis
    Riancho, Javier
    Ruiz-Soto, Maria
    Berciano, Maria T.
    Berciano, Jose
    Lafarga, Miguel
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
  • [29] Neuroinflammation in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis
    Hensley, K
    Ferrell, S
    Floyd, RA
    Mhatre, M
    Mou, SY
    Pye, QN
    Stewart, C
    West, M
    Williamson, K
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S433 - S434
  • [30] Effects of Tongue Force Training on Bulbar Motor Function in the Female SOD1-G93A Rat Model of Amyotrophic Lateral Sclerosis
    Ma, Delin
    Shuler, Jeffrey M.
    Kumar, Aishwarya
    Stanford, Quincy R.
    Tungtur, Sudheer
    Nishimune, Hiroshi
    Stanford, John A.
    NEUROREHABILITATION AND NEURAL REPAIR, 2017, 31 (02) : 147 - 156